Neil W Gibson of OSI Pharmaceuticals

Jeffrey Settleman,  Harvard Medical School and MGH Cancer Center

David Bailey of Chemoventures

N Claude Cohen of Synergix

-View All Webcasts

Bristol-Myers: A Hot Takeover Target?

April 7, 2008--Bristol-Myers Squibb is an attractive takeover candidate for a larger pharma such as Pfizer or Sanofi-Aventis, says Brian Marckx of Zacks Investment Research. Bristol-Myers’ Plavix (clopidogrel bisulfate; an anti-platelet agent), Marckx says, is helping drive earnings growth to nearly 20% in 2008. BusinessWeek